carvedilol has been researched along with Coxsackie Virus Infections in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study was therefore designed to examine the effects of carvedilol on the transcriptional factor CREB in a murine model of acute viral myocarditis." | 7.79 | Effects of carvedilol treatment on cardiac cAMP response element binding protein expression and phosphorylation in acute coxsackievirus B3-induced myocarditis. ( Li-Sha, G; Na-Dan, Z; Teng, Z; Yi-He, C; Yue-Chun, L, 2013) |
| "The study was designed to compare the effects of ivabradine and carvedilol in acute viral myocarditis." | 7.78 | Comparison of effects of ivabradine versus carvedilol in murine model with the Coxsackievirus B3-induced viral myocarditis. ( Jia-Feng, L; Li-Sha, G; Na-Dan, Z; Qin, L; Teng, Z; Xue-Qiang, G; Yue-Chun, L, 2012) |
| "Carvedilol, a nonselective beta-blocker with additional alpha1-adrenergic blocking and antioxidant properties, has been shown to be cardioprotective in experimental myocarditis." | 7.74 | Protective effects of carvedilol in murine model with the coxsackievirus B3-induced viral myocarditis. ( Ji-Fei, T; Jia-Feng, L; Jiang-Hua, R; Li-Sha, G; Peng, C; Peng-Lin, Y; Yue-Chun, L; Zhan-Qiu, Y, 2008) |
| "In a coxsackievirus B3 murine myocarditis model (BALB/c), effects of carvedilol and metoprolol on myocardial cytokine expression, inflammatory cell infiltration and MMP/TIMP profiles were investigated." | 7.73 | Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis association with reduced myocardial interleukin-1beta and MMP-8 expression and a modulated immune response. ( Chandrasekharan, K; Li, J; Noutsias, M; Pauschinger, M; Peter Schwimmbeck, L; Poller, W; Rutschow, S; Schultheiss, HP; Tschope, C; Weitz, A; Westermann, D; Zeichhardt, H, 2005) |
| "Carvedilol, a vasodilating nonselective beta-adrenoceptor antagonist, but not metoprolol, a selective beta1-adrenoceptor antagonist, has been shown to increase the production of cardiac antiinflammatory cytokines in experimental myocarditis." | 7.72 | Hemodynamic characterization of left ventricular function in experimental coxsackieviral myocarditis: effects of carvedilol and metoprolol. ( Noutsias, M; Pauschinger, M; Rutschow, S; Schultheiss, HP; Schwimmbeck, PL; Steendijk, P; Tschöpe, C; Weitz, A; Westermann, D, 2004) |
| "This study was therefore designed to examine the effects of carvedilol on the transcriptional factor CREB in a murine model of acute viral myocarditis." | 3.79 | Effects of carvedilol treatment on cardiac cAMP response element binding protein expression and phosphorylation in acute coxsackievirus B3-induced myocarditis. ( Li-Sha, G; Na-Dan, Z; Teng, Z; Yi-He, C; Yue-Chun, L, 2013) |
| "The study was designed to compare the effects of ivabradine and carvedilol in acute viral myocarditis." | 3.78 | Comparison of effects of ivabradine versus carvedilol in murine model with the Coxsackievirus B3-induced viral myocarditis. ( Jia-Feng, L; Li-Sha, G; Na-Dan, Z; Qin, L; Teng, Z; Xue-Qiang, G; Yue-Chun, L, 2012) |
| "Carvedilol, a nonselective beta-blocker with additional alpha1-adrenergic blocking and antioxidant properties, has been shown to be cardioprotective in experimental myocarditis." | 3.74 | Protective effects of carvedilol in murine model with the coxsackievirus B3-induced viral myocarditis. ( Ji-Fei, T; Jia-Feng, L; Jiang-Hua, R; Li-Sha, G; Peng, C; Peng-Lin, Y; Yue-Chun, L; Zhan-Qiu, Y, 2008) |
| "In a coxsackievirus B3 murine myocarditis model (BALB/c), effects of carvedilol and metoprolol on myocardial cytokine expression, inflammatory cell infiltration and MMP/TIMP profiles were investigated." | 3.73 | Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis association with reduced myocardial interleukin-1beta and MMP-8 expression and a modulated immune response. ( Chandrasekharan, K; Li, J; Noutsias, M; Pauschinger, M; Peter Schwimmbeck, L; Poller, W; Rutschow, S; Schultheiss, HP; Tschope, C; Weitz, A; Westermann, D; Zeichhardt, H, 2005) |
| "Carvedilol, a vasodilating nonselective beta-adrenoceptor antagonist, but not metoprolol, a selective beta1-adrenoceptor antagonist, has been shown to increase the production of cardiac antiinflammatory cytokines in experimental myocarditis." | 3.72 | Hemodynamic characterization of left ventricular function in experimental coxsackieviral myocarditis: effects of carvedilol and metoprolol. ( Noutsias, M; Pauschinger, M; Rutschow, S; Schultheiss, HP; Schwimmbeck, PL; Steendijk, P; Tschöpe, C; Weitz, A; Westermann, D, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li-Sha, G | 3 |
| Yi-He, C | 1 |
| Na-Dan, Z | 2 |
| Teng, Z | 2 |
| Yue-Chun, L | 3 |
| Qin, L | 1 |
| Xue-Qiang, G | 1 |
| Jia-Feng, L | 2 |
| Li, YC | 1 |
| Luo, Q | 1 |
| Ge, LS | 1 |
| Chen, YH | 1 |
| Zhou, ND | 1 |
| Zhang, T | 1 |
| Guan, XQ | 1 |
| Lin, JF | 1 |
| Tschöpe, C | 2 |
| Westermann, D | 2 |
| Steendijk, P | 1 |
| Noutsias, M | 2 |
| Rutschow, S | 2 |
| Weitz, A | 2 |
| Schwimmbeck, PL | 1 |
| Schultheiss, HP | 2 |
| Pauschinger, M | 2 |
| Chandrasekharan, K | 1 |
| Peter Schwimmbeck, L | 1 |
| Zeichhardt, H | 1 |
| Poller, W | 1 |
| Li, J | 1 |
| Jiang-Hua, R | 1 |
| Peng-Lin, Y | 1 |
| Ji-Fei, T | 1 |
| Peng, C | 1 |
| Zhan-Qiu, Y | 1 |
6 other studies available for carvedilol and Coxsackie Virus Infections
| Article | Year |
|---|---|
Effects of carvedilol treatment on cardiac cAMP response element binding protein expression and phosphorylation in acute coxsackievirus B3-induced myocarditis.
Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Coxsackievirus Infectio | 2013 |
Comparison of effects of ivabradine versus carvedilol in murine model with the Coxsackievirus B3-induced viral myocarditis.
Topics: Adrenergic beta-Antagonists; Animals; Apoptosis; Benzazepines; Carbazoles; Carvedilol; Coxsackieviru | 2012 |
Ivabradine inhibits the production of proinflammatory cytokines and inducible nitric oxide synthase in acute coxsackievirus B3-induced myocarditis.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Benzazepines; Carbazoles; Carvedilol; Coxsackievir | 2013 |
Hemodynamic characterization of left ventricular function in experimental coxsackieviral myocarditis: effects of carvedilol and metoprolol.
Topics: Animals; Carbazoles; Carvedilol; Coxsackievirus Infections; Male; Metoprolol; Mice; Mice, Inbred BAL | 2004 |
Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis association with reduced myocardial interleukin-1beta and MMP-8 expression and a modulated immune response.
Topics: Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Coxsackievirus Infections; Interleukin | 2005 |
Protective effects of carvedilol in murine model with the coxsackievirus B3-induced viral myocarditis.
Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents; Antioxidants; Carbazo | 2008 |